RPRX - CIK 0001802768
Royalty Pharma plc has filed 588 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (283 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Company correspondence | CORRESP | 2025-04-04 | - |
| Insider trade | 4 | 2025-04-01 | 2025-03-31 |
| Insider trade | 4 | 2025-04-01 | 2025-03-31 |
| SEC correspondence | UPLOAD | 2025-03-28 | - |
| Proxy materials | DEFA14A | 2025-03-05 | - |
| SCHEDULE 13D/A | - | 2025-02-21 | - |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| PREM14A | - | 2025-02-13 | 2025-02-12 |
| Annual report | 10-K | 2025-02-12 | 2024-12-31 |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| Major company event | 8-K | 2025-02-11 | 2025-02-11 |
| SCHEDULE 13G | - | 2025-02-04 | - |
| Proxy materials | DEFA14A | 2025-01-17 | - |
| Proxy materials | DEFA14A | 2025-01-16 | - |
| 425 | - | 2025-01-15 | - |
| Proxy materials | DEFA14A | 2025-01-13 | - |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Major company event | 8-K | 2025-01-10 | 2025-01-10 |
| Proxy materials | DEFA14A | 2025-01-10 | - |
| Major company event | 8-K | 2025-01-10 | 2025-01-10 |
| Insider trade | 4 | 2025-01-02 | 2024-12-31 |
| Insider trade | 4 | 2025-01-02 | 2024-12-31 |
| Major company event | 8-K | 2024-12-31 | 2024-12-31 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-08 | - |
| Quarterly report | 10-Q | 2024-11-06 | 2024-09-30 |
| Major company event | 8-K | 2024-11-06 | 2024-11-06 |
| Insider trade | 4 | 2024-09-30 | 2024-09-30 |
| Insider trade | 4 | 2024-09-30 | 2024-09-30 |
| Major company event | 8-K | 2024-09-27 | 2024-09-26 |
| Insider trade | 4 | 2024-08-12 | 2024-08-12 |
| Insider trade | 4 | 2024-08-12 | 2024-08-12 |
| Insider trade | 4 | 2024-08-12 | 2024-08-12 |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| Major company event | 8-K | 2024-08-07 | 2024-08-06 |
| Activist ownership stake (update) | SC 13D/A | 2024-07-29 | - |
| Insider trade | 4 | 2024-06-28 | 2024-06-28 |
| Insider trade | 4 | 2024-06-28 | 2024-06-28 |
| Major company event | 8-K | 2024-06-20 | 2024-06-17 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Insider trade | 4 | 2024-06-10 | 2024-06-07 |
| Major company event | 8-K | 2024-06-10 | 2024-06-10 |
| Major company event | 8-K | 2024-06-06 | 2024-06-06 |
| Prospectus supplement | 424B5 | 2024-06-04 | - |
| Major company event | 8-K | 2024-06-04 | 2024-06-03 |